Serum-responsive expression of carbonyl-metabolizing enzymes in normal and transformed human buccal keratinocytes

Cellular and Molecular Life Sciences

Volumn 65, Issue 22, 2008, Pages 3653-3663

  Staab, C A ^a   Ceder, R ^a   Roberg, K ^b   Grafstrom R C ^a,c   Hoog J O ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Buccal mucosa; Carbonyl metabolizing enzymes; Microarray; Quinone metabolism; Serum effects; Terminal squamous differentiation; Xenobiotic metabolism

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A3; ALDEHYDE DEHYDROGENASE 3A1; ALDEHYDE DEHYDROGENASE 3B1; ALDEHYDE DEHYDROGENASE 4A1; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALDO KETO REDUCTASE 1A1; CELL DIVISION CONTROL PROTEIN 2 HOMOLOG; CELL MARKER; CYCLINE; CYTOKERATIN 13; CYTOKERATIN 4; DIHYDROPTERIDINE REDUCTASE; ESTRADIOL 17 BETA DEHYDROGENASE 2; INVOLUCRIN; MENADIONE; OXIDOREDUCTASE; PHENANTHRENEQUINONE; SHORT CHAIN DEHYDROGENASE REDUCTASE 3; SMALL PROLINE RICH PROTEIN 3; TRANSGLUTAMINASE 1; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL LYSATE; CELL PROLIFERATION; CELL TRANSFORMATION; CHEEK MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; EPITHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; MICROARRAY ANALYSIS; MOUTH CAVITY; PROTEIN EXPRESSION; PROTEIN FOLDING; SERUM RESPONSIVE ELEMENT; SQUAMOUS CELL; XENOBIOTIC METABOLISM;

CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KERATINOCYTES; MOUTH MUCOSA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDOREDUCTASES;

EID: 56549096779     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8554-8     Document Type: Article

References (62)

1. Squier C. A. and Kremer M. J. (2001) Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 29, 7-15.
2. Presland R. B. and Dale B. A. (2000) Epithelial structural proteins of the skin and oral cavity: Function in health and disease. Crit. Rev. Oral Biol. Med. 11, 383-408.
3. Sundqvist K., Liu Y., Arvidson K., Ormstad K., Nilsson L., Toftgård R. and Grafström R. C. (1991) Growth regulation of serum-free cultures of epithelial cells from normal human buccal mucosa. In Vitro Cell. Dev. Biol. 27A, 562-568.
4. Nilsson J. A., Hedberg J. J., Vondracek M., Staab C. A., Hansson A., Höög J. O. and Grafström R. C. (2004) Alcohol dehydrogenase 3 transcription associates with proliferation of human oral keratinocytes. Cell. Mol. Life Sci. 61, 610-617.
5. Grafström R. C. (2002) Human oral epithelium. In: Culture of Epithelial Cells, pp. 195-255, Freshney I. R. and Freshney M. G. (eds.) John Wiley and Sons, New York.
6. Eckert R. L. and Welter J. F. (1996) Epidermal keratinocytes - Genes and their regulation. Cell Death Differ. 3, 373-383.
7. Lippens S., Denecker G., Ovaere P., Vandenabeele P. and Declercq W. (2005) Death penalty for keratinocytes: Apoptosis versus cornification. Cell Death Differ. 12 Suppl 2, 1497-1508.
8. Sundqvist K., Kulkarni P., Hybbinette S. S., Bertolero F., Liu Y. and Grafström R. C. (1991) Serum-free growth and karyotype analyses of cultured normal and tumorous (SqCC/Y1) human buccal epithelial cells. Cancer Commun. 3, 331-340.
9. Kulkarni P. S., Sundqvist K., Betsholtz C., Höglund P., Wiman K. G., Zhivotovsky B., Bertolero F., Liu Y. and Grafström R. C. (1995) Characterization of human buccal epithelial cells transfected with the simian virus 40 T-antigen gene. Carcinogenesis 16, 2515-2521.
10. Sacks P. G. (1996) Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev. 15, 27-51.
11. Ceder R., Merne M., Staab C. A., Nilsson J. A., Höög J. O., Dressler D., Engelhart K. and Grafström R. C. (2007) The application of normal, SV40 T-antigen-immortalised and tumour-derived oral keratinocytes, under serum-free conditions, to the study of the probability of cancer progression as a result of environmental exposure to chemicals. Altern. Lab. Anim. 35, 621-639.
12. Wertz P. W. and Squier C. A. (1991) Cellular and molecular basis of barrier function in oral epithelium. Crit. Rev. Ther. Drug Carrier Syst. 8, 237-269.
13. Shojaei A. H. (1998) Buccal mucosa as a route for systemic drug delivery: A review. J. Pharm. Pharm. Sci. 1, 15-30.
14. Vondracek M., Xi Z., Larsson P., Baker V., Mace K., Pfeifer A., Tjalve H., Donato M. T., Gomez-Lechon M. J. and Grafström R. C. (2001) Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 22, 481-488.
15. Vondracek M., Weaver D. A., Sarang Z., Hedberg J. J., Willey J. C., Wärngåérd L. and Grafström R. C. (2002) Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes. Int. J. Cancer 99, 776-782.
16. Hedberg J. J., Grafström R. C., Vondracek M., Sarang Z., Wärngåérd L. and Höög J.O. (2001) Micro-array chip analysis of carbonyl-metabolising enzymes in normal, immortalised and malignant human oral keratinocytes. Cell. Mol. Life Sci. 58, 1719-1726.
17. Matsunaga T., Shintani S. and Hara A. (2006) Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. 21, 1-18.
18. Oppermann U. (2007) Carbonyl reductases: The complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology. Annu. Rev. Pharmacol. Toxicol. 47, 293-322.
19. Hoffmann F. and Maser E. (2007) Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily. Drug Metab. Rev. 39, 87-144.
20. Jin Y. and Penning T. M. (2007) Aldo-keto reductases and bioactivation/detoxication. Annu. Rev. Pharmacol. Toxicol. 47, 263-292.
21. Oppermann U. C. and Maser E. (2000) Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. Toxicology 144, 71-81.
22. Bianchet M. A., Faig M. and Amzel L. M. (2004) Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO). Methods Enzymol. 382, 144-174.
23. Pappa A., Estey T., Manzer R., Brown D. and Vasiliou V. (2003) Human aldehyde dehydrogenase 3A1 (ALDH3A1): Biochemical characterization and immunohistochemical localization in the cornea. Biochem. J. 376, 615-623.
24. O'Connor T., Ireland L. S., Harrison D. J. and Hayes J. D. (1999) Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 343, 487-504.
25. Fernández M. R., Porté S., Crosas E., Barberà N., Farrés J., Biosca J. A. and Parés X. (2007) Human and yeast zetacrystallins bind AU-rich elements in RNA. Cell. Mol. Life Sci. 64, 1419-1427.
26. Wermuth B., Platts K. L., Seidel A. and Oesch F. (1986) Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochem. Pharmacol. 35, 1277-1282.
27. Lind C., Cadenas E., Hochstein P. and Ernster L. (1990) DT-diaphorase: Purification, properties, and function. Methods Enzymol. 186, 287-301.
28. Schlegel B. P., Ratnam K. and Penning T. M. (1998) Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine. Biochemistry 37, 11003-11011.
29. Rao P. V., Krishna C. M. and Zigler J. S. Jr. (1992) Identification and characterization of the enzymatic activity of zeta-crystallin from guinea pig lens. A novel NADPH:quinone oxidoreductase. J. Biol. Chem. 267, 96-102.
30. Forrest G. L., Gonzalez B. (2000) Carbonyl reductase. Chem. Biol. Interact. 129, 21-40.
31. Atalla A., Breyer-Pfaff U. and Maser E. (2000) Purification and characterization of oxidoreductases catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol. Xenobiotica 30, 755-769.
32. Ernster L., Danielson L. and Ljunggren M. (1962) DT diaphorase. I. Purification from the soluble fraction of ratliver cytoplasm, and properties. Biochim. Biophys. Acta 58, 171-188.
33. Ahmed N. K., Felsted R. L. and Bachur N. R. (1979) Comparison and characterization of mammalian xenobiotic ketone reductases. J. Pharmacol. Exp. Ther. 209, 12-19.
34. Staab C. A., Ceder R., Jägerbrink T., Nilsson J. A., Roberg K., Jörnvall H., Höög J. O. and Grafström R. C. (2007) Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J. Proteome Res. 6, 3705-3717.
35. Roberg K., Ceder R., Farnebo L., Norberg-Spaak L. and Grafström R. C. (2008) Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture. Differentiation 76, 868-880.
36. Tusher V. G., Tibshirani R. and Chu G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121.
37. Saeed A. I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V. and Quackenbush J. (2003) TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34, 374-378.
38. m" aldehyde dehydrogenase and its identification as glutamic γ-semialdehyde dehydrogenase. J. Biol. Chem. 261, 2154-2163.
39. Yoon K. A., Nakamura Y. and Arakawa H. (2004) Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet. 49, 134-140.
40. Reiss M., Brash D. E., Munoz-Antonia T., Simon J. A., Ziegler A., Vellucci V. F. and Zhou Z. L. (1992) Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol. Res. 4, 349-357.
41. Truong A. B. and Khavari P. A. (2007) Control of keratinocyte proliferation and differentiation by p63. Cell Cycle 6, 295-299.
42. Änggård E. and Samuelsson B. (1965) Biosynthesis of prostaglandins from arachidonic acid in guinea pig lung. Prostaglandins and related factors. 38. J. Biol. Chem. 240, 3518-3521.
43. Jarabak J. (1992) Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase. Arch. Biochem. Biophys. 292, 239-243.
44. Yan M., Rerko R. M., Platzer P., Dawson D., Willis J., Tong M., Lawrence E., Lutterbaugh J., Lu S., Willson J. K., Luo G., Hensold J., Tai H. H., Wilson K. and Markowitz S. D. (2004) 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers. Proc. Natl. Acad. Sci. USA 101, 17468-17473.
45. Tong M., Ding Y. and Tai H. H. (2006) Histone deacetylase inhibitors and transforming growth factor-β induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells. Biochem. Pharmacol. 72, 701-709.
46. Masui T., Wakefield L. M., Lechner J. F., LaVeck M. A., Sporn M. B. and Harris C. C. (1986) Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83, 2438-2442.
47. Tai H. H., Tong M. and Ding Y. (2007) 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer. Prostaglandins Other Lipid Mediat. 83, 203-208.
48. Barski O. A., Papusha V. Z., Kunkel G. R. and Gabbay K. H. (2004) Regulation of aldehyde reductase expression by STAF and CHOP. Genomics 83, 119-129.
49. Maytin E. V. and Habener J. F. (1998) Transcription factors C/EBP α, C/EBP β, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J. Invest. Dermatol. 110, 238-246.
50. Rexer B. N., Zheng W. L. and Ong D. E. (2001) Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res. 61, 7065-7070.
51. Fuchs E. and Green H. (1981) Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 25, 617-625.
52. Cerignoli F., Guo X., Cardinali B., Rinaldi C., Casaletto J., Frati L., Screpanti I., Gudas L. J., Gulino A., Thiele C. J. and Giannini G. (2002) retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines. Cancer Res. 62, 1196-1204.
53. Krook M., Marekov L. and Jörnvall H. (1990) Purification and structural characterization of placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family. Biochemistry 29, 738-743.
54. Penning T. M., Mukharji I., Barrows S. and Talalay P. (1984) Purification and properties of a 3 α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem. J. 222, 601-611.
55. 2α by aldehyde reductase from human liver: Comparison to the prostaglandin F synthetase from bovine lung. J. Biol. Chem. 264, 1036-1040.
56. Maser E. and Oppermann U. C. (1997) Role of type-1 11β- hydroxysteroid dehydrogenase in detoxification processes. Eur. J. Biochem. 249, 365-369.
57. Wermuth B. (1981) Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. J. Biol. Chem. 256, 1206-1213.
58. Gustafson D. L. and Pritsos C. A. (1992) Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarol. Cancer Res. 52, 6936-6939.
59. Sato S. and Kador P. F. (1990) Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochem. Pharmacol. 40, 1033-1042.
60. Komoto J.,Yamada T., Watanabe K. and Takusagawa F. (2004) Crystal structure of human prostaglandin F synthase (AKR1C3). Biochemistry 43, 2188-2198.
61. Donato M. T., Lahoz A., Castell J. V. and Gomez-Lechon M. J. (2008) Cell lines: A tool for in vitro drug metabolism studies. Curr. Drug Metab. 9, 1-11.
62. Di Luccio E., Elling R. A. and Wilson D. K. (2006) Identification of a novel NADH-specific aldo-keto reductase using sequence and structural homologies. Biochem. J. 400, 105-114.